郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价WAY-100635 is a potent dopamine D4 receptor agonist.

期刊：Psychopharmacology发表年份：2006作者：Benjamin R Chemel; Bryan L Roth; Blaine Armbruster; Val J Watts; David E Nichols
阅读更多 →

药效评价Estrogen and CCK1 receptor modification of mu-opioid receptor binding in the cortex of female rats.

期刊：Brain research发表年份：2006作者：Arnulfo Quesada; Paul Micevych
阅读更多 →

药效评价Reversal of MDR1 gene-dependent multidrug resistance using low concentration of endonuclease-prepared small interference RNA.

期刊：European journal of pharmacology发表年份：2006作者：Lin Li; Jianfeng Xu; Taishan Min; Weida Huang
阅读更多 →

药效评价Novel ligands for the human histamine H1 receptor: synthesis, pharmacology, and comparative molecular field analysis studies of 2-dimethylamino-5-(6)-phenyl-1,2,3,4-tetrahydronaphthalenes.

期刊：Bioorganic & medicinal chemistry发表年份：2006作者：Ola M Ghoneim; Jacqueline A Legere; Alexander Golbraikh; Alexander Tropsha; Raymond G Booth
阅读更多 →